Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentration.
Journal: Journal of internal medicine
Published: February 03, 2022
Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.
Journal: Molecular systems biology
Published: March 04, 2017
Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: February 09, 2016
Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 14, 2015
Association between skeletal muscle fat content and very-low-density lipoprotein-apolipoprotein B-100 transport in obesity: effect of weight loss.
Journal: Diabetes, obesity & metabolism
Published: January 13, 2014
Atorvastatin plus omega-3 fatty acid ethyl ester decreases very-low-density lipoprotein triglyceride production in insulin resistant obese men.
Journal: Diabetes, obesity & metabolism
Published: July 15, 2013
Showing 1-6 of 6
Last Updated: 09/26/2026